GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1

被引：0
|
作者：
Yu Tang
Gaosai Dai
Yupeng Yang
Huantao Liu
机构：
[1] Cancer Hospital of China Medical University,Day Ward
[2] Liaoning Cancer Hospital and Institute,Department of Breast Surgery
[3] Qilu Hospital of Shandong University,Department of Thyroid and Breast Surgery
[4] Jinan Zhangqiu District Hospital of TCM,undefined
来源：
Journal of Translational Medicine | / 21卷
关键词：
BC; GSG2; Prognosis; Phenotype; E2F1; Ubiquitination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Recruitment of Pontin/Reptin by E2F1 amplifies E2F transcriptional response during cancer progression
    Tarangelo, Amy
    Lo, Nathanael
    Teng, Rebecca
    Kim, Eunsun
    Raman, Pichai
    Viatour, Patrick
    [J]. MOLECULAR CANCER RESEARCH, 2016, 14
  • [42] Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression
    Tarangelo, Amy
    Lo, Nathanael
    Teng, Rebecca
    Kim, Eunsun
    Le, Linh
    Watson, Deborah
    Furth, Emma E.
    Raman, Pichai
    Ehmer, Ursula
    Viatour, Patrick
    [J]. NATURE COMMUNICATIONS, 2015, 6
  • [43] MEK inhibition enhances gemcitabine efficacy by increasing MDM2-mediated ubiquitination and degradation of RRM1
    Vena, F.
    Li Causi, E.
    Hagemann, T.
    Hartley, J. A.
    Goodstal, S.
    Hochhauser, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 146 - 146
  • [44] Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression
    Amy Tarangelo
    Nathanael Lo
    Rebecca Teng
    Eunsun Kim
    Linh Le
    Deborah Watson
    Emma E. Furth
    Pichai Raman
    Ursula Ehmer
    Patrick Viatour
    [J]. Nature Communications, 6
  • [45] KAT2A affects tumor metabolic reprogramming in colon cancer progression through epigenetic activation of E2F1
    Han, Xiaofeng
    Chen, Jie
    [J]. HUMAN CELL, 2022, 35 (04) : 1140 - 1158
  • [46] KAT2A affects tumor metabolic reprogramming in colon cancer progression through epigenetic activation of E2F1
    Xiaofeng Han
    Jie Chen
    [J]. Human Cell, 2022, 35 : 1140 - 1158
  • [47] LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation
    Zeng, Kaixuan
    Chen, Xiaoxiang
    Hu, Xiuxiu
    Liu, Xiangxiang
    Xu, Tao
    Sun, Huiling
    Pan, Yuqin
    He, Bangshun
    Wang, Shukui
    [J]. ONCOGENE, 2018, 37 (41) : 5534 - 5551
  • [48] Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination
    O'Keefe, K
    Li, HP
    Zhang, YP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (18) : 6396 - 6405
  • [49] HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53
    Wang, Yuhong
    Hu, Lin
    Wang, Jian
    Li, Xiangwei
    Sahengbieke, Sana
    Wu, Jingjing
    Lai, Maode
    [J]. JOURNAL OF PATHOLOGY, 2018, 246 (04): : 508 - 518
  • [50] STIMULATION OF E2F1/DP1 TRANSCRIPTIONAL ACTIVITY BY MDM2 ONCOPROTEIN
    MARTIN, K
    TROUCHE, D
    HAGEMEIER, C
    SORENSEN, TS
    LATHANGUE, NB
    KOUZARIDES, T
    [J]. NATURE, 1995, 375 (6533) : 691 - 694
12345